The U.K. has made the ban on puberty blockers for children with gender dysphoria indefinite, while the U.S. Supreme Court heard arguments for a case that may set a precedent for a similar ban in the U.S. The UK Commission on Human Medicines (CHM) determined that GnRH agonists, commonly referred to as puberty blockers, pose an “unacceptable safety risk for children and young people under 18 years without significant additional safeguards.”

In April, The HighWire reported about the release of the Cass report, a new study regarding gender dysphoria, and the temporary ban on puberty blocker prescriptions for children in the U.K.  Hilary Cass concluded that there isn’t any reliable long-term data to support the safety of these medications for children.

A study published in April found that the highest rate of gender “non-contentedness” is highest at the age of 11 before puberty typically takes place. While 21-22% of children experience gender-related distress, only 2% continue to experience that distress into adulthood.

The CHM notes that children who have been taking puberty blockers in the six months preceding June 3, 2024 can still obtain prescriptions but will not be able to get these medications from their primary care doctor or general practitioner. The CHM also states that additional mental health and psychological services may be necessary for children who have begun treatment, but will not be able to access puberty blockers under the new order.

The United States Supreme Court also heard arguments this month challenging a gender affirming care ban for minors in Tennessee. The Biden administration, along with a Memphis physician and three families with transgender teens, claims that Tennessee’s ban violates the equal protection clause of the 14th Amendment. The justices were asked to examine whether the law is being applied equally regardless of sex.

Justice Sonya Sotomayor argued that a female child who appears gender-neutral and seeks medication to prevent breasts from growing would be prescribed the medication while a male child in the same circumstance would be denied. Tennessee’s Solicitor General Matthew Rice said the law hinges entirely upon medical purpose and thus doesn’t discriminate based upon sex. If the medical purpose is precocious puberty, then the medication will be made available, while the medical purpose of gender dysphoria would prevent the child from obtaining puberty blockers.

The justices raised concerns about the court’s decision to make medical decisions rather than allowing the public to vote. Chase Strangio, a transgender male attorney arguing against Tennessee, echoed Sotomayor’s statement that the ban discriminates against girls with gender dysphoria. In contrast, males with precocious puberty are allowed access to the same medication.

Justice Alito had an exchange with Strangio asking about the immutability of gender identity. Strangio said, “I think that the record shows that the discordance between a person’s birth sex, and gender identity has a strong biological basis and would satisfy an immutability test.”

Alito asked, “Does transgender status apply to individuals who are gender fluid?” He followed that up by asking if there were transgender individuals who, at one point, identified as their birth sex. Strangio agreed that there are people like that. Alito responded, “So, it’s not an immutable characteristic, is it?” The decision for the supreme court case is expected to come in the summer of 2025.

In October, Jeffrey Jaxen reported on Dr. Johanna Olson’s refusal to publish the results of a 9-year study of almost 100 children who received puberty blockers. Dr. Olson said the drugs did not improve mental health in children and believes the results would be weaponized.

The study reportedly cost $9.7 million and was funded by U.S. taxpayers through the NIH. House Representative and Chair of the  Committee on Oversight and Accountability Lisa McClain wrote a letter to Director Monica Bertagnolli demanding accountability and transparency from the NIH following Olson’s refusal to release the results from the study.

Rep McClain claimed that Dr. Olson misinterpreted data from a Trans Youth Care study, which followed 95 children who were given puberty blockers and followed their mental health outcomes over two years. According to McClain, Dr. Olson concluded that the study showed no mental health change over the two years and that puberty blockers have no adverse impact on mental health. The study, however, found two-thirds of the participants reported suicidal ideation, and of those, 25% attempted suicide at least once.

Rep McClain wrote, “Dr. Olson-Kennedy’s apparent mischaracterization of the TYC study’s results and refusal to publish taxpayer-funded research because they contradict her pre-existing biases and could be cited by critics of ‘gender-affirming’ medical interventions is an irrefutable example of politicization of scientific research to further an ideological agenda.  Deliberately mischaracterizing and withholding the results of the TYC study has serious implications for the health and safety of children who are subjected to “gender-affirming” medical procedures, many of which are irreversible and hold lifelong implications despite lacking adequate scientific support for their efficacy or safety.”

Rep McClain added, “NIH has a duty to conduct oversight of its extramural research grants and ensure that its funded research exemplifies its purported principles of scientific integrity.” On behalf of the Committee on Oversight and Accountability, McClain requested unpublished research, data, and progress reports related to the study in question. McClain requested that the NIH comply with these document requests by November 18, but no further update has been provided on the request.

President-elect Donald Trump stated that he will encourage Congress to “pass a law prohibiting child sexual mutilation in all 50 states.” Trump said, “It will go very quickly. I will declare that any hospital or health care provider that participates in the chemical or physical mutilation of minor youth will no longer meet federal health and safety standards for Medicaid and Medicare and will be terminated from the program immediately.”

The HighWire reported about a lawsuit in January in which Fenway Community Health declared immunity from lawsuits for misdiagnosing and causing injury to a detransitioner. Fenway claims it has immunity under the Federal Tort Claims Act, which is something that protects many gender clinics from liability when harm is caused to patients.

 

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy